Karyopharm Therapeutics

company

Number of Lead Investors

Number of Investors

Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Avidity Partners	Yes	Post-IPO Equity
Foresite Capital	Yes	Series B
Chione	Yes	Series A
Multiple Myeloma Research Foundation	Yes	Grant
Adage Capital Management	-	Post-IPO Equity
Armistice Capital	-	Post-IPO Equity
HealthCor Partners	-	Post-IPO Equity
Heights Capital Management	-	Post-IPO Equity
Marshall Wace	-	Post-IPO Equity
Rubric Capital Management	-	Post-IPO Equity
SilverArc Capital	-	Post-IPO Equity
Surveyor Capital	-	Post-IPO Equity
Delphi Ventures	-	Series B
New Leaf Venture Partners	-	Series B